Lv1
8 积分 2024-07-23 加入
Dual-payload antibody–drug conjugates: Taking a dual shot
18天前
已完结
Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
18天前
已完结
Dual-payload ADCs move into first oncology clinical trials
18天前
已完结
Abstract 386: High CRBN expression in neuroendocrine cancer creates a vulnerability to GSPT1 molecular glue degraders: Target indication selection for CYRS1542 development
1个月前
已完结
The role of synthetic lethality in overcoming cancer therapy resistance: Emerging paradigm and recent advances
1个月前
已完结
A systematic analysis of the landscape of synthetic lethality-driven precision oncology
1个月前
已完结
Abstract A124: CBB-120: A TROP2-targeted dual-payload ADC combining Top1i and ATRi mechanisms demonstrates superior efficacy in preclinical models and improved safety in non-human primates
1个月前
已完结
Abstract 4427: Development of CLIO-8221: A HER2-targeted multi-payload ADC to address ADC resistance
1个月前
已完结
The role of synthetic lethality in overcoming cancer therapy resistance: Emerging paradigm and recent advances
1个月前
已完结
Context-dependent synthetic lethality — an emerging precision therapeutic approach
1个月前
已完结
皖公网安备34019202002308
